Syk modulates cell survival in various human hematopoietic malignancies; overexpression of Syk promotes survival of non-Hodgkin’s lymphoma cell lines [8] and limits differentiation of AML cell lines [9]. Here, SYK is linked to acute myeloid leukemia.